"For many VA clinicians, the choice was also driven by the side-effect profile," he pointed out. "Most VA PTSD patients are
Vietnam veterans, who are now in their 60s and 70s. This population has higher lifetime rates of smoking and alcohol use disorders
than the general population, and is at risk for obesity, hypertension, diabetes, coronary artery disease, and cerebrovascular
disease. Risperidone is associated with fewer contraindications for these patients and initially was the SGA most commonly
prescribed for this population."